SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-015690
Filing Date
2020-08-14
Accepted
2020-08-14 08:44:07
Documents
82
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 984713
2 ex3-1.htm EX-3.1 10235
3 ex10-1.htm EX-10.1 5075
4 ex31-1.htm EX-31.1 19416
5 ex31-2.htm EX-31.2 19753
6 ex32-1.htm EX-32.1 8090
7 ex10-1_001.jpg GRAPHIC 134524
8 ex10-1_002.jpg GRAPHIC 70346
9 ex10-1_003.jpg GRAPHIC 185785
10 ex10-1_004.jpg GRAPHIC 176083
11 ex10-1_005.jpg GRAPHIC 164486
  Complete submission text file 0001493152-20-015690.txt   5468927

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE clsn-20200630.xml EX-101.INS 644653
13 XBRL SCHEMA FILE clsn-20200630.xsd EX-101.SCH 67923
14 XBRL CALCULATION FILE clsn-20200630_cal.xml EX-101.CAL 73074
15 XBRL DEFINITION FILE clsn-20200630_def.xml EX-101.DEF 201499
16 XBRL LABEL FILE clsn-20200630_lab.xml EX-101.LAB 431649
17 XBRL PRESENTATION FILE clsn-20200630_pre.xml EX-101.PRE 300620
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 201101577
SIC: 2834 Pharmaceutical Preparations